As part of the reprioritization, SAGE will focus on the commercialization of its depression drug Zurzuvae (zuranolone), which ...
Strategic restructuring will support the ongoing launch of the oral postpartum depression drug, Zurzuvae, and extend Sage’s ...
Sage said in an SEC filing that it expects a non-recurring charge tied to the workforce reduction of $26 million to $28 ...
US biotech company Sage Therapeutics is to slash a third of its remaining jobs - just a year after cutting 40% of its prior workforce.
Needham analyst Ami Fadia has reiterated their neutral stance on SAGE stock, giving a Hold rating on October 10. Ami Fadia’s rating is ...
Sage Therapeutics Inc.’s stock slid 4.7% Thursday, after the biotech said it’s cutting about 33% of its workforce as part of ...
Last year, there was further disappointment for the company after another drug partnered with Biogen, Zurzuvae (zuranolone), was approved by the FDA for postpartum depression (PPD), but turned ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...
Copyright 2024 The Associated Press. All Rights Reserved. The U.S. military trained him in explosives and battlefield tactics. But after two tours in Iraq, Chris ...
After hours of speculation, Israel has confirmed they successfully killed Yahya Sinwar, the architect of the October 7 attack last year. The IDF announced on Thursday morning that Sinwar was one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback